[포스트 IPO]⑥ 의료AI 강자 씨어스…2028년 씽크 재계약 주목

Ceres' insurance reimbursement for thynC breaks the profitability deadlock endemic to Korean medical AI companies, achieving the industry's first semi-annual profit and record-setting margins. The convergence of 2028 hospital contract renewals, next-generation system deployment, and high switching costs from deep EMR integration creates a compounding growth trajectory that fundamentally transforms the financial viability of medical AI businesses.